Evidence map›Paper›PMID 36105748›Full record

ArticleClinical, cosmetic and investigational dermatology2022

Coexistence of Riehl's Melanosis, Lupus Erythematosus and Thyroiditis in a Patient.

Kuan Lai, Xinyao Zheng, Shanshan Wei, Huifeng Zhou, Xuedan Zeng, Guixin Liang, Zhiwen Zhang, Wenjing Zhang

Open access · goldAbstract readCase Reports
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Global consensus on the management of melanin hyperpigmentation disorders.Journal of the European Academy of Dermatology and Venereology : JEADV · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kuan LaiDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xinyao ZhengDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Shanshan WeiDepartment of Dermatology, Zhujiang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Huifeng ZhouDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Xuedan ZengDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Guixin LiangDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Zhiwen ZhangDepartment of Dermatology, Nanfang Hospital, Southern Medical University, Guangzhou, People's Republic of China.
Wenjing ZhangDepartment of Dermatology, The First Affiliated Hospital of Jinan University, Guangzhou, People's Republic of China.ORCID 0000-0002-7812-6274
Nanfang Hospital · CNFirst Affiliated Hospital of Jinan University · CNZhujiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Riehl's melanosis (RM) is an acquired hyperpigmentation disorder, presenting diffused and reticulate brownish-gray pigmentation, preferentially on the face and neck. RM overlaps with systemic lupus erythematosus (SLE) and Hashimoto's thyroiditis has never been reported. Case: We report a case of RM patient accompanied with SLE and Hashimoto's thyroiditis of primary hypothyroidism. Progressing, diffuse, symmetric, and reticular hyperpigmentation was seen on the face, neck, and upper limbs, manifesting as typical melanosis. Skin microscopy showed diffuse black-pepper-like changes and telangiectasias. The diagnosis of SLE and primary hypothyroidism were confirmed by follow-up investigations. The hyperpigmentation turned notably lighter after 14 months of treatment with prednisone, hydroxychloroquine, and L-thyroxine. Discussion: The exact pathogenesis of RM is unclear and exposure to coal tar dyes, ultraviolet, and fragrance fixatives in cosmetics are believed to be contributing factors, while some cases involve no triggers. It is not impossible that RM is a rare skin manifestation of SLE that has never been reported. The skin hyperpigmentation in this patient was not triggered by thyroid disease. Conclusion: RM could be a skin manifestation of autoimmunity. Coexistence of RM, lupus erythematosus and thyroiditis in the same patient is rare and has never been reported.

Indexed as

case reportcutaneous lupus erythematosusmelanosisprimary hypothyroidismsystemic lupus erythematosus

Identifiers

PMID36105748
PMCPMC9467848
OpenAlexW4295018433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.